Clinical short-term results of radiofrequency ablation in liver cancers

查看全文 作　　者：Hong-Chi Jiang Lian-Xin Liu Da-Xun Piao Jun Xu An-Long Zhu Wei-Hui Zhang Lin-Feng Wu Department of Surgery,the First Clinical College,Harbin Medical University,Harbin 150001,Heilongjiang Province,China Min Zheng Department of Ultrasound Diagnosis,the First Clinical College,Harbin Medical University,Harbin 150001,Heilongjiang Province,China Shu-Yi Qi Second Inpatient Department,the First Clinical College,Harbin Medical University,Harbin 150001,Heilongjiang Province,China

出　　处：《World Journal of Gastroenterology》索引2002年第8卷第4期,共7页

基　　金：Youth Natural Scientific Foundation of Heilongjiang Province;Youth Natural Scientific Foundation of Harbin;Heilongjiang Province Education Government Grant 摘　　要：AIM: To study local therapeutic efficacy, side effects, andcomplications of radiofrequency ablation (RFA), whichis emerging as a new method for the treatment ofpatients with hepatocellular carcinoma (HCC) withcirrhosis or chronic hepatitis and metastatic liver cancer.METHODS: Thirty-six patients with primary andsecondary liver cancers (21 with primaryhepatocellular carcinoma, 12 with colorectal cancerliver metastases and 3 with other malignant livermetastases), which were considered not suitable forcurative resection, were include in this study. Theywere treated either with RFA (RITA2000, MountainView, California, USA) percutaneously (n=20)orintraoperatively (n=16).The procedures wereperformed using the ultrasound guidance. The qualityof RFA were based on monitoring of equipments andsubject feeling of the practitioners. Patients treatedwith RFA was followed according to clinical findings,radiographic images, and tumor markers.RESULTS: Thirty-six patients underwent RFA for 48nodules. RFA was used to treat an average 1.3 lesionsper patient, and the median size of treated lesions was2.5 cm (range, 0.5-9 cm). The average hospital staywas 5.6 days overall (2.8 days for percutaneous casesand 7.9 days for open operations). Seven patientsunderwent a second RFA procedure (sequentialablations). Sixteen HCC patients with a high level ofalpha fetoprotein (AFP) and 9 colorectal cancer livermetastases patients with a high level of serumcarcinoembryonic antigen (CEA) have a great reductionbenefited from RFA. Four (11.1 %) patients hadcomplications: one skin burn; one postoperativehemorrhage; one cholecystitis and one hepatic abscessassociated with percutaneous ablations of a largelesion. There were 4 deaths: 3 patients died from localand system diseases (1 at 7 month, 1 at 9 month, and 1at 12 month), 1 patients died from cardiovascular shock,but no RFA-related death. At a median follow-up of 10months (range, 1-24 months), 6 patients (16.7 %) hadrecurrences at an RFA site, and 20 patients (56.7 %)remained clinically free of disease.CONCLUSION: RF ablation appears to be an effective,safe, and relatively simple procedure for the treatmentof unresectable liver cancers. The rate and severity ofcomplications appear acceptable. However, furtherstudy is necessary to assess combination with othertherapies, long-term recurrence rates and effect onoverall survival. 关键词：射频消融术肺癌近期疗效影像学检查治疗

相关文献

参考文献（10）
引证文献（34）
耦合文献（84）

参考文献(10)

引证文献(34)

耦合文献(84)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Clinical short-term results of radiofrequency ablation in liver cancers

参考文献(10)

引证文献(34)

耦合文献(84)

用户提示